$163 Million is the total value of DCF Advisers, LLC's 67 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -20,000 | -100.0% | -0.02% | – |
| PAAS | Exit | PAN AMERN SILVER CORPcall | $0 | – | -10,000 | -100.0% | -0.11% | – |
| Exit | ESPERION THERAPEUTICS INC NEnote 4.000%11/1 | $0 | – | -3,600,000 | -100.0% | -0.13% | – | |
| PEO | Exit | ADAM NAT RES FD INC | $0 | – | -10,000 | -100.0% | -0.15% | – |
| XLE | Exit | SELECT SECTOR SPDR TRput | $0 | – | -2,500 | -100.0% | -0.15% | – |
| TGNA | Exit | TEGNA INC | $0 | – | -12,500 | -100.0% | -0.18% | – |
| XBI | Exit | SPDR SER TRs&p biotech | $0 | – | -3,500 | -100.0% | -0.20% | – |
| MCHI | Exit | ISHARES TRmsci china etf | $0 | – | -8,358 | -100.0% | -0.27% | – |
| Exit | TURNING PT BRANDS INC2.500% 7/1 | $0 | – | -500,000 | -100.0% | -0.30% | – | |
| C | Exit | CITIGROUP INC | $0 | – | -10,000 | -100.0% | -0.31% | – |
| DXC | Exit | DXC TECHNOLOGY CO | $0 | – | -18,500 | -100.0% | -0.33% | – |
| PYPL | Exit | PAYPAL HLDGS INC | $0 | – | -7,000 | -100.0% | -0.34% | – |
| TSM | Exit | TAIWAN SEMICONDUCTOR MFG LTDcall | $0 | – | -7,500 | -100.0% | -0.38% | – |
| SHY | Exit | ISHARES TRput | $0 | – | -11,500 | -100.0% | -0.63% | – |
| NFLX | Exit | NETFLIX INC | $0 | – | -3,400 | -100.0% | -0.68% | – |
| VOO | Exit | VANGUARD INDEX FDSput | $0 | – | -5,000 | -100.0% | -1.19% | – |
| TPB | Exit | TURNING PT BRANDS INC | $0 | – | -83,113 | -100.0% | -1.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTRA-CELLULAR THERAPIES INC | 16 | Q3 2023 | 10.2% |
| MICRON TECHNOLOGY INC | 16 | Q3 2023 | 6.7% |
| ALPHABET INC | 16 | Q3 2023 | 5.8% |
| ABBVIE INC | 16 | Q3 2023 | 7.9% |
| REGENERON PHARMACEUTICALS | 16 | Q3 2023 | 5.5% |
| ARGENX SE | 16 | Q3 2023 | 6.4% |
| SPDR GOLD TRUST | 16 | Q3 2023 | 6.6% |
| XENCOR INC | 16 | Q3 2023 | 4.1% |
| BK OF AMERICA CORP | 16 | Q3 2023 | 5.4% |
| ORACLE CORP | 16 | Q3 2023 | 3.2% |
View DCF Advisers, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-15 |
View DCF Advisers, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.